GlaxoSmithKline Pharmaceuticals reply to clarification sought by the exchange

09 Jun 2015 Evaluate

The Exchange had sought clarification from GlaxoSmithKline Pharmaceuticals with respect to news appearing in Business Standard dated June 06, 2015 titled ‘CCI slaps Rs 64 cr fine on GlaxoSmithKline, Sanofi.’ GlaxoSmithKline Pharmaceuticals response is enclosed.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2311.50 -68.35 (-2.87%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×